id paper:paper_00468177_v41_n5_p697_Carlini
record_format dspace
spelling paper:paper_00468177_v41_n5_p697_Carlini2023-06-08T15:05:32Z Mast cell phenotypes and microvessels in non-small cell lung cancer and its prognostic significance Puricelli, Lydia Inés Lauria de Cidre, Lilia Intratumoral Lung cancer Mast cell phenotypes Microvessels Peritumoral CD34 antigen chymase tryptase adult aged article cancer survival cell infiltration controlled study female human human tissue immunohistochemistry lung lobectomy lung non small cell cancer major clinical study male mast cell microvasculature phenotype prognosis Age Factors Aged Aged, 80 and over Carcinoma, Non-Small-Cell Lung Chi-Square Distribution Female Humans Immunohistochemistry Lung Lung Neoplasms Male Mast Cells Microvessels Middle Aged Neoplasm Staging Neovascularization, Pathologic Prognosis Proportional Hazards Models Retrospective Studies Statistics, Nonparametric The impact of interstitial inflammatory cells, such as mast cells, and angiogenesis on the prognosis of cancer patients has been reported in many solid tumors, although there is disagreement about their role. We undertook a retrospective study with tissue samples from 65 patients with stage I and II non-small cell lung cancer to assess the clinical pathologic role and prognostic significance of mast cells. Mast cell phenotypes were identified by immunohistochemistry for tryptase and chymase. In addition, we identified microvessels using the endothelial marker CD34. Mast cell and microvessel density was quantified by assessing immunopositive cells in the intratumoral and peritumoral zones of tumor specimens. Both mast cell and microvessel density was higher in the peritumoral zone than the intratumoral zone (P ≤ .05). A positive correlation between mast cell (tryptase-chymase phenotype) and microvessel densities was observed in the intratumoral zone (P ≤ .05), supporting the involvement of mast cells in the angiogenic process. Regarding survival, a subset of stage I patients had a worse prognosis at five years when low mast cell (tryptase-chymase phenotype) density was found in the peritumoral zone (median survival in months [range]: 27 [1-60] versus 46 [1-60]). Multivariate Cox analysis indicated that this parameter may be an independent prognostic factor (P ≤ .05) useful for selecting candidates for earlier treatment. © 2010 Elsevier Inc. All rights reserved. Fil:Puricelli, L.I. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Lauría de Cidre, L.S. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. 2010 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00468177_v41_n5_p697_Carlini http://hdl.handle.net/20.500.12110/paper_00468177_v41_n5_p697_Carlini
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic Intratumoral
Lung cancer
Mast cell phenotypes
Microvessels
Peritumoral
CD34 antigen
chymase
tryptase
adult
aged
article
cancer survival
cell infiltration
controlled study
female
human
human tissue
immunohistochemistry
lung lobectomy
lung non small cell cancer
major clinical study
male
mast cell
microvasculature
phenotype
prognosis
Age Factors
Aged
Aged, 80 and over
Carcinoma, Non-Small-Cell Lung
Chi-Square Distribution
Female
Humans
Immunohistochemistry
Lung
Lung Neoplasms
Male
Mast Cells
Microvessels
Middle Aged
Neoplasm Staging
Neovascularization, Pathologic
Prognosis
Proportional Hazards Models
Retrospective Studies
Statistics, Nonparametric
spellingShingle Intratumoral
Lung cancer
Mast cell phenotypes
Microvessels
Peritumoral
CD34 antigen
chymase
tryptase
adult
aged
article
cancer survival
cell infiltration
controlled study
female
human
human tissue
immunohistochemistry
lung lobectomy
lung non small cell cancer
major clinical study
male
mast cell
microvasculature
phenotype
prognosis
Age Factors
Aged
Aged, 80 and over
Carcinoma, Non-Small-Cell Lung
Chi-Square Distribution
Female
Humans
Immunohistochemistry
Lung
Lung Neoplasms
Male
Mast Cells
Microvessels
Middle Aged
Neoplasm Staging
Neovascularization, Pathologic
Prognosis
Proportional Hazards Models
Retrospective Studies
Statistics, Nonparametric
Puricelli, Lydia Inés
Lauria de Cidre, Lilia
Mast cell phenotypes and microvessels in non-small cell lung cancer and its prognostic significance
topic_facet Intratumoral
Lung cancer
Mast cell phenotypes
Microvessels
Peritumoral
CD34 antigen
chymase
tryptase
adult
aged
article
cancer survival
cell infiltration
controlled study
female
human
human tissue
immunohistochemistry
lung lobectomy
lung non small cell cancer
major clinical study
male
mast cell
microvasculature
phenotype
prognosis
Age Factors
Aged
Aged, 80 and over
Carcinoma, Non-Small-Cell Lung
Chi-Square Distribution
Female
Humans
Immunohistochemistry
Lung
Lung Neoplasms
Male
Mast Cells
Microvessels
Middle Aged
Neoplasm Staging
Neovascularization, Pathologic
Prognosis
Proportional Hazards Models
Retrospective Studies
Statistics, Nonparametric
description The impact of interstitial inflammatory cells, such as mast cells, and angiogenesis on the prognosis of cancer patients has been reported in many solid tumors, although there is disagreement about their role. We undertook a retrospective study with tissue samples from 65 patients with stage I and II non-small cell lung cancer to assess the clinical pathologic role and prognostic significance of mast cells. Mast cell phenotypes were identified by immunohistochemistry for tryptase and chymase. In addition, we identified microvessels using the endothelial marker CD34. Mast cell and microvessel density was quantified by assessing immunopositive cells in the intratumoral and peritumoral zones of tumor specimens. Both mast cell and microvessel density was higher in the peritumoral zone than the intratumoral zone (P ≤ .05). A positive correlation between mast cell (tryptase-chymase phenotype) and microvessel densities was observed in the intratumoral zone (P ≤ .05), supporting the involvement of mast cells in the angiogenic process. Regarding survival, a subset of stage I patients had a worse prognosis at five years when low mast cell (tryptase-chymase phenotype) density was found in the peritumoral zone (median survival in months [range]: 27 [1-60] versus 46 [1-60]). Multivariate Cox analysis indicated that this parameter may be an independent prognostic factor (P ≤ .05) useful for selecting candidates for earlier treatment. © 2010 Elsevier Inc. All rights reserved.
author Puricelli, Lydia Inés
Lauria de Cidre, Lilia
author_facet Puricelli, Lydia Inés
Lauria de Cidre, Lilia
author_sort Puricelli, Lydia Inés
title Mast cell phenotypes and microvessels in non-small cell lung cancer and its prognostic significance
title_short Mast cell phenotypes and microvessels in non-small cell lung cancer and its prognostic significance
title_full Mast cell phenotypes and microvessels in non-small cell lung cancer and its prognostic significance
title_fullStr Mast cell phenotypes and microvessels in non-small cell lung cancer and its prognostic significance
title_full_unstemmed Mast cell phenotypes and microvessels in non-small cell lung cancer and its prognostic significance
title_sort mast cell phenotypes and microvessels in non-small cell lung cancer and its prognostic significance
publishDate 2010
url https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00468177_v41_n5_p697_Carlini
http://hdl.handle.net/20.500.12110/paper_00468177_v41_n5_p697_Carlini
work_keys_str_mv AT puricellilydiaines mastcellphenotypesandmicrovesselsinnonsmallcelllungcanceranditsprognosticsignificance
AT lauriadecidrelilia mastcellphenotypesandmicrovesselsinnonsmallcelllungcanceranditsprognosticsignificance
_version_ 1768544997322260480